MRNA - Moderna, Inc.
IEX Last Trade
40.35
-0.130 -0.322%
Share volume: 84,657
Last Updated: Fri 27 Dec 2024 02:30:08 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.33%
PREVIOUS CLOSE
CHG
CHG%
$40.48
-0.13
-0.32%
Summary score
9%
Profitability
6%
Dept financing
8%
Liquidity
56%
Performance
0%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2020 - 30-Jun-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
7.21%
Return on assets
3.61%
Return on sales
-107.72%
Return on invested capital
-61.01%
Total debt ratio
37.69%
Debt ratio change over timeo
0.65%
Current Ratio
2.44%
Quick Ratio
2.28%
Cash Position Ratio
1.85%
Short-term ratios 30-Jun-2023 - 30-Jun-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-11.38%
Return on assets
-6.64%
Return on sales
-358.33%
Return on invested capital
-35.14%
Total debt ratio
26.08%
Debt ratio change over timeo
-0.15%
Current Ratio
3.5%
Quick Ratio
3.38%
Cash Position Ratio
2.94%
Last quarter ratios 30-Jun-2024
The data are presented for the financials results of the last quarter.
Return on equity
-10.92%
Return on assets
-8.69%
Return on sales
-565.56%
Return on invested capital
-34.98%
Total debt ratio
25.31%
Debt ratio change over time
-1.72%
Current Ratio
4.09%
Quick Ratio
3.92%
Cash Position Ratio
3.59%
Performance ratios (change over 4 years) 30-Jun-2020 - 30-Jun-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-118.44%
Return on assets
-119.79%
Return on sales
-1139.53%
Return on invested capital
-19.37%
Total debt ratio
65.07%
Debt ratio change over time
0.65%
Current Ratio
27.88%
Quick Ratio
25.82%
Cash Position Ratio
21.13%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | MRNA | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 7.21% | 15.05% | 35.64% | 7.13% |
| Return on assets | 3.61% | 2.88% | 3.13% | 5.53% |
| Return on sales | -107.72% | 29.62% | 32.25% | 40.49% |
| Return on invested capital | -61.01% | 2.57% | 5.37% | 18.48% |
| Profitability | 21% | 45% | 66% | 80% |
| Total debt ratio | 37.69% | 90.48% | 91% | 25.78% |
| Debt ratio change over time | 0.65% | 326.95% | -8.44% | 1.18% |
| Dept financing | 10% | 50% | 25% | 7% |
| Current Ratio | 3.5% | 0.92% | 1.98% | 5.39% |
| Quick Ratio | 3.38% | 0.81% | 1.56% | 4.63% |
| Cash Position Ratio | 2.94% | 0.39% | 1.05% | 2.91% |
| Liquididy | 49% | 14% | 31% | 75% |
| Short-term ratios | MRNA | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -11.38% | 13.14% | 10.88% | 4.07% |
| Return on assets | -6.64% | 2.1% | 1.54% | 3.03% |
| Return on sales | -358.33% | 21.74% | 18.43% | 30.26% |
| Return on invested capital | -35.14% | 1.95% | 2.74% | 9.55% |
| Profitability | 0% | 65% | 56% | 83% |
| Total debt ratio | 26.08% | 92.68% | 93.24% | 21.84% |
| Debt ratio change over time | -0.15% | 51.04% | -101.54% | 1.43% |
| Dept financing | 7% | 50% | 25% | 7% |
| Current Ratio | 3.5% | 0.92% | 1.98% | 5.39% |
| Quick Ratio | 3.38% | 0.81% | 1.56% | 4.63% |
| Cash Position Ratio | 2.94% | 0.39% | 1.05% | 2.91% |
| Liquididy | 59% | 12% | 27% | 75% |